OAM
LOXO

Oxford Asset Management’s Loxo Oncology, Inc LOXO Stock Holding History

Oxford Asset Management’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-35,225
Closed -$963K – 935
2016
Q1 		$963K Buy
+35,225
New +$737K 0.03% 510

Other funds holding LOXO

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Oxford Asset Management's LOXO Position: Q2 2016 in Review

Oxford Asset Management sold out of Loxo Oncology, Inc (LOXO) in Q2 2016, closing a stake of 35,225 shares — an estimated $963K sold.

Oxford Asset Management first reported a position in LOXO in Q1 2016 and held it in 1 quarter. The position peaked at $963K in Q1 2016. 73 funds tracked by Wall St. Rank hold LOXO as of Q2 2016.

  • Oxford Asset Management reported no remaining Loxo Oncology, Inc position as of Q2 2016 after selling out during the quarter.
  • Oxford Asset Management sold 35,225 Loxo Oncology, Inc shares in Q2 2016, an estimated $963K.
  • Oxford Asset Management first reported a position in Loxo Oncology, Inc in Q1 2016 and held it in 1 quarter.
  • Oxford Asset Management's Loxo Oncology, Inc position peaked at $963K in Q1 2016.
  • 73 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q2 2016.

Based on Oxford Asset Management's 13F filing for Q2 2016, filed 8 Aug 2016.